Results 201 to 210 of about 398,508 (313)

WCN25-3335 PREDICTIVE FOCTORS FOR THE USE OF HEMODIALYSIS DURING SEVERE ACUTE KIDNEY INJURY FOLLOWING PRE-ECLAMPSIA

Kidney International Reports
Driss Benali, mohammed Benabdelhak, imane Machmachi, intissar Haddiya, yassamine Bentata   +4 more
doaj   +1 more source

Pediatric heart-kidney transplantation. [PDF]

JHLT Open
Choudhry S, Puri K, Dharnidharka VR.
europepmc   +1 more source

Hyperparathyroidism after kidney homotransplantation [PDF]

, 1987
Geis, WP, Hammond, WS, Huffer, WE, Popovtzer, MM, Starzl, TE   +4 more
core  

Tacrolimus exposure during pregnancy in kidney and liver transplantation recipients: A comparison between whole blood and plasma concentration‐to‐dose ratios

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Tacrolimus monitoring is generally performed in whole blood (WB). Most (>85%) of circulating tacrolimus is bound to red blood cells. During pregnancy, WB monitoring might be suboptimal because of physiological changes including increased plasma volume and decreased haematocrit.
Jildau R. Meinderts, Paola Mian, Frederike G. I. van Vilsteren, Karien M. H. van de Wetering, Jelmer R. Prins, Stefan P. Berger, Daan J. Touw, Margriet F. C. de Jong   +7 more
wiley   +1 more source

Thrombotic microangiopathy after kidney transplantation: diagnosis and management strategies. [PDF]

Clin Kidney J
Mirioglu S, Morelle J, Efe O, Hurdogan O, Dirim AB, Kumru G, Lentine KL, Caliskan Y.   +7 more
europepmc   +1 more source

The pretreatment principle in renal transplantation as illustrated by thoracic duct drainage [PDF]

, 1980
Koep, LJ, Starzl, TE, Weil, R
core  

Possible therapeutic repositioning of valproic acid: From epileptic seizures to acute kidney injury

British Journal of Clinical Pharmacology, EarlyView.
Valproic acid, an anticonvulsant, may be repositioned to prevent acute kidney injury due to ischemia followed by reperfusion. It preserves renal functions, electrolyte homeostasis and active sodium transport in kidney tubules, and blocks the onset of hypertension.
Danilo Alves‐Bezerra, Luiza B. Negreiros, Amaury Pereira‐Acácio, Isadora G. Almeida, João P. M. Veloso‐Santos, Jarlene A. Lopes, Glória Costa‐Sarmento, Humberto Muzi‐Filho, Adalberto Vieyra   +8 more
wiley   +1 more source

Hyperphosphataemia, but not hypercalcaemia, predicts cardiovascular risk after kidney transplantation. [PDF]

Clin Kidney J
Agur T, Steinmetz T, Haran M, Rahamimov R, Goldman S, Nagel N, Meisel E, Zingerman B, Nesher E, Rozen-Zvi B.   +9 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Kidney transplantation in obese Black patients: Strategies to improve access and outcomes. [PDF]

World J Nephrol
Oluyombo R, Karim M, Mason S, Halawa A.
europepmc   +1 more source